People: Jazz Pharmaceuticals, Inc. (JAZZ.O)

JAZZ.O on Consolidated Issue listed on NASDAQ Global Market

9.18USD
9 Feb 2010
Price Change (% chg)

$0.05 (+0.55%)
Prev Close
$9.13
Open
$9.29
Day's High
$9.45
Day's Low
$9.15
Volume
72,043
Avg. Vol
184,194
52-wk High
$11.88
52-wk Low
$0.51

view people for:

Gamble, Carol 

Brief Biography

Ms. Carol A. Gamble serves as Senior Vice President, General Counsel and Corporate Secretary of Jazz Pharmaceuticals, Inc. Ms. Gamble is Senior Vice President in 2004 and has served as General Counsel and Corporate Secretary of Jazz Pharmaceuticals since 2003. From 2002 to 2003, she served as a consultant to various companies in the pharmaceutical industry. From 2000 to 2002, she served as General Counsel and Corporate Secretary of Aerogen, a biopharmaceutical company acquired by Nektar Therapeutics. From 1988 to 2000, she held various positions with ALZA Corporation, most recently as its Senior Vice President and Chief Corporate Counsel. She received a B.S. from Syracuse University and a J.D. from the University of California, Berkeley, Boalt Hall.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
357,267 -- 99,938 457,205

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total
Cozadd, Bruce 649,018
Myers, Robert 630,995
Falberg, Kathryn --
Gamble, Carol 457,205
Wissel, Janne --
Colligan, Joan --
As Of 30 Dec 2008
view people for: